NXGL

NexGel Inc Common Stock (NXGL)

Stock · NASDAQ · Health Care

$5.46as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 7, 2026

NXGL Listed Among 12 Health Care Stocks Moving in Pre‑Market Session. NXGL was one of 12 health‑care stocks that moved in Wednesday’s pre‑market session. The move reflects short‑term interest in the sector. The stock is trading near its 52‑week low and has a low RSI, which may have contributed to the pre‑market activity.

Active signals

Support level
$0.547125
Industry
Medical/Dental Instruments

What NXGL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike40-4.2%35%
Bollinger Band BreakoutActive now21-7.8%29%
Bollinger Band Breakdown19+4.6%63%
200-Day Moving Average TouchActive now13-0.7%46%
Any 20-session window (baseline)-2.6%43%

Computed by MarketWall from daily closing prices since October 7, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About NXGL

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
19

Fundamentals

1-day range
$5.1$5.87
Market cap
$3.13M
P/E (trailing)
—
P/E (forward)
-1.27
EPS (trailing)
$-0.72
Dividend yield
—
Beta
0.82
Avg. volume
104.6K
52-week range
$3$57
Next earnings: November 10, 2026 · EPS estimate $-4.80confirmed

How NexGel Inc Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$11.42MSG&A$7.86M (69%)Cost of Revenue$6.91M (61%)R&D$2.0K (0%)NXGL

Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub

Gross Profit$4.51M(39%)
Operating Income-$3.35M(-29%)

Forecasts

1 analyst ratings

Buy 0%
Hold 50%
Sell 50%
1-year price forecast
High
$2
-63.3%
Median
$2
-63.3%
Low
$2
-63.3%

NexGel Inc Common Stock Competitors

Chosen by industry and closest market cap.

  • NXGL
    NexGel Inc Common Stock
    $5.59
    ▲ 7.92%
    Market cap $3.13MP/E —
    $3$57
  • IVF
    INVO Fertility Inc. Common Stock
    $0.558
    ▼ 5.58%
    Market cap $2.39MP/E —
    $0.58$84.4
  • GCTK
    GlucoTrack Inc. Common Stock
    $0.725
    ▼ 12.86%
    Market cap $4.25MP/E 0.07
    $1.77$136.29
  • TNON
    Tenon Medical Inc. Common Stock
    $2.7
    ▼ 7.22%
    Market cap $1.99MP/E —
    $2.4$50.4
  • AEMD
    Aethlon Medical Inc. Common Stock
    $5.15
    ▼ 2.28%
    Market cap $1.96MP/E —
    $1.41$35.95
  • VVOS
    Vivos Therapeutics Inc. Common Stock
    $0.131
    ▼ 8.39%
    Market cap $4.47MP/E —
    $0.1276$3.28
  • INBS
    Intelligent Bio Solutions Inc. Common Stock
    $1.5
    ▲ 4.17%
    Market cap $4.76MP/E —
    $1.35$24.9

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
1.21M
Disposed
35.0K

Institutional Ownership

March 31, 2026

Total shares held
457.7K
Total value held
$279.4K
Institutional holders
17
Top holders this quarter
  • Unknown128.5K
  • Unknown55.0K
  • Unknown51.0K
  • Unknown42.1K
  • Unknown35.7K
  • Unknown34.0K
  • Unknown20.0K
  • Unknown19.3K
  • Unknown17.6K
  • Unknown17.3K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.